For instance, our analysis may exhibit bias as patients in non-EUR gAncestry populations tended to present with higher tumour grade (potentially due to increased ER- and/or enrichment of BRCA1/2 mutations), which is associated with decreased overall survival. The gene discussed is BRCA1; the disease is neoplasm.